MedTrace Logo

L-glutamine Treatment in Patients With Diverticulosis

NCT05106101 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2023-02-16

No results posted yet for this study

Summary

The purpose of the study is evaluate the safety and efficacy of L-glutamine as a treatment for patients with diverticulosis.

Conditions

  • Diverticulosis, Colonic

Interventions

DRUG

L-glutamine

L-glutamine oral powder in 5 gram packet

Sponsors & Collaborators

  • Emmaus Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Yutaka L Niihara, MD · Emmaus Medical, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-19
Primary Completion
2022-12-30
Completion
2022-12-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05106101 on ClinicalTrials.gov